(Q51716057)

English

Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya.

scientific article published on 6 February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya. (English)

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

0 references

anti-retroviral agent

0 references

author name string

R Zachariah

1

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

I Van Engelgem

2

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

M Massaquoi

3

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

L Kocholla

4

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

M Manzi

5

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

A Suleh

6

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

M Phillips

7

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

M Borgdorff

8

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

publication date

6 February 2008

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

102

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

3

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

288-293

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Preventing antiretroviral anarchy in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Adherence to HAART and its principal determinants in a cohort of Senegalese adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Universal access to antiretroviral therapy may be the best approach to ‘Do no harm’ in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2007.12.007

7 January 2021

Identifiers

10.1016/J.TRSTMH.2007.12.007

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

1 reference

Europe PubMed Central

10 April 2018

http://europepmc.org/abstract/MED/18258272

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51716057&oldid=1457537958"